dizocilpine-maleate and Bronchial-Hyperreactivity

dizocilpine-maleate has been researched along with Bronchial-Hyperreactivity* in 2 studies

Other Studies

2 other study(ies) available for dizocilpine-maleate and Bronchial-Hyperreactivity

ArticleYear
Study of the interaction of glutamatergic and nitrergic signalling in conditions of the experimental airways hyperreactivity.
    Pharmacological reports : PR, 2013, Volume: 65, Issue:3

    Glutamatergic and nitrergic system participate in the control of respiratory system functions. It is only little information regarding a possible interaction of both systems in the airways hyperractivity. We investigated the effect of agents modulating the activity of these systems on the experimental ovalbumin-induced airways hyperreactivity as well as on the changes of exhaled nitric oxide (eNO) levels.. We used the agonists of NMDA receptors - N-methyl-D-aspartic acid (NMDA) and monosodium glutamate (MSG), selective competitive antagonist (DL-2-amino-5-phosphonovaleric acid - AP-5) and selective non-competitive antagonist (dizocilpine - MK-801) of these receptors. We used also non-specific inhibitor of NO synthases N(ω)-nitro-L-arginine methyl ester (L-NAME). The airways responsiveness to histamine or acetylcholine was evaluated under in vitro conditions.. NMDA administration caused the increase of tracheal smooth muscle response in ovalbumin-induced hyperreactivity to acetylcholine. The effect of MSG was less pronounced. MK-801 as well as AP-5 provoked the decrease of reactivity mainly to acetylcholine in tracheal smooth muscle. We recorded the changes in eNO levels. The activation of NMDA receptor with NMDA or MSG increased eNO levels. The inhibition of NO synthase with L-NAME caused the fall of eNO levels. MK-801 shows (within the group) the more expressive effect in the eNO levels during sensitization than AP-5 group.. The results confirm the possibility of NMDA receptors participation in the experimental airways hyperreactivity.

    Topics: 2-Amino-5-phosphonovalerate; Acetylcholine; Animals; Bronchial Hyperreactivity; Dizocilpine Maleate; Excitatory Amino Acid Agents; Guinea Pigs; Histamine; Male; Muscle, Smooth; N-Methylaspartate; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Receptors, N-Methyl-D-Aspartate; Sodium Glutamate; Trachea

2013
Eicosanoids modulate hyperpnea-induced late phase airway obstruction and hyperreactivity in dogs.
    Respiration physiology, 2002, Volume: 129, Issue:3

    A canine model of exercise-induced asthma was used to test the hypothesis that the development of a late phase response to hyperventilation depends on the acute production of pro-inflammatory mediators. Peripheral airway resistance, reactivity to hypocapnia and aerosol histamine, and bronchoalveolar lavage fluid (BALF) cell and eicosanoid content were measured in dogs approximately 5 h after dry air challenge (DAC). DAC resulted in late phase obstruction, hyperreactivity to histamine, and neutrophilic inflammation. Both cyclooxygenase and lipoxygenase inhibitors administered in separate experiments attenuated the late phase airway obstruction and hyperreactivity to histamine. Neither drug affected the late phase inflammation nor the concentrations of eicosanoids in the BALF obtained 5 h after DAC. This study confirms that hyperventilation of peripheral airways with unconditioned air causes late phase neutrophilia, airway obstruction, and hyperreactivity. The late phase changes in airway mechanics are related to the hyperventilation-induced release of both prostaglandins and leukotrienes, and appear to be independent of the late phase infiltration of inflammatory cells.

    Topics: Air; Airway Obstruction; Animals; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Dizocilpine Maleate; Dogs; Eicosanoids; Humidity; Hyperventilation; Indomethacin; Male; Respiration

2002